También conocido como: Copper peptide · Glycyl-L-histidyl-L-lysine copper
A copper-binding tripeptide investigated in skin-matrix and wound-research literature.
§ In brief
A copper-binding tripeptide investigated in skin-matrix and wound-research literature.
GHK-Cu is catalogued here as a reference compound for tissue-repair and regenerative research. The entry covers its chemical identity and the public databases that describe it; it is not a usage guide.
GHK-Cu appears in the tissue-repair and regenerative literature, primarily in in-vitro and preclinical (animal) models. This page indexes 3 primary papers on GHK-Cu, each tagged with its study type below. Peptidoteca summarizes the proposed mechanism class and the primary sources rather than human outcomes; for the wider library, see the research library.
No. GHK-Cu is supplied for laboratory (in-vitro) research use only. It is not approved by the FDA or any comparable regulator for human or veterinary use, and nothing on this page constitutes medical advice, dosing guidance or a treatment recommendation.
Most available evidence for GHK-Cu is preclinical — in-vitro and animal models — and findings in those models do not establish efficacy or safety in humans. Human clinical data is limited or absent, and GHK-Cu is not an approved drug. Treat the literature as mechanistic research, not clinical guidance.
§ Primary literature
Solo para investigación in-vitro. No es consejo médico, clínico ni de dosificación.